The COVID-19 pandemic ignited research centered around the identification of robust
biomarkers and therapeutic targets. SARS-CoV-2, the virus responsible, hijacks the …

Several studies and research papers have been published to elucidate and understand the
mechanism of the coronavirus disease 2019 (COVID-19) pandemic and its long-term effects …

Around 10% of adults infected with SARS-CoV-2 that survive a first episode of COVID-19
appear to experience long-term clinical manifestations. The signs and symptoms of this post …

During an infectious disease progression, it is crucial to understand the cellular
heterogeneity underlying the differential immune response landscape that will augment the …

Exogenous estrogen is associated with reduced coronavirus disease (COVID) mortality in
nonimmunosuppressed/immunocompromised (non-ISC) postmenopausal females. Here …

Background Although COVID-19 has been linked to worse acute outcomes in patients with
some neurodegenerative disorders, its long-term impact on dementia remains unclear …

Background: In the context of the SARS-CoV-2 pandemic, our interest was to evaluate the
effect of COVID-19 during pregnancy on placenta and coagulation factors. Methods: a …

Long COVID-19 is characterized by ongoing symptoms or prolonged or long-term
complications of SARS-CoV-2 contraction which persist beyond 4 weeks from the initial …

For COVID-19 survivors, defeating the virus is just the beginning of a long road to recovery.
The inducibility and catastrophic effects of the virus are distributed across multiple organs …

The coronavirus disease 2019 (COVID-19) pandemic has claimed many lives since it was
first reported in late December 2019. However, there is still no drug proven to be effective …